论文信息 - PIVOT-12: a Phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence. - 字舞流文

PIVOT-12: a Phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence.

D. Schadendorf | P. Ascierto | G. Boland | A. Eggermont | H. Gogas | G. Long | K. Lewis | M. Carlino | J. Weber | S. Currie | D. Chien | M. Tagliaferri | N. Khushalani | A. Diab | M. Majem | G. Rivalland | Daniel H Johnson | A. Khattak